Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:37 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3UnknownINTERVENTIONAL

Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT02461173 · Registry updated: 2016-07-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Ovulation detection (procedure)
Choriomon (drug)
shepherd catheter (device)

Where the study takes place — 2 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Letrozole in Assisted Reproductive Technology

ClinicalTrials.gov · NCT02429999 · Registry updated: 2016-07-15

Condition / research focus: to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-04. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrezole plus FSH (drug)
Standard protocol for induction of ovulation (drug)

Where the study takes place — 1 listed sites

of Medicine
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

ClinicalTrials.gov · NCT02827656 · Registry updated: 2016-07-12

Condition / research focus: Infertility
Sponsor: Meir Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-08. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Decapeptyl (drug)
hCG luteal support (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

ClinicalTrials.gov · NCT02349945 · Registry updated: 2016-07-12

Condition / research focus: Male Infertility
Sponsor: Azienda USL Modena
Countries with listed sites: Germany · Italy
Registry dates and results: Start: 2011-01. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

follitropin alpha (drug) — also listed as: Gonal f

Where the study takes place — 6 listed sites

Zentrums für Reproduktions-medizin und Andrologie Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg
Halle, Germany
Site recruitment: Not reported
Dipartimento di Ginecologia e Medicina della Riproduzione IRCCS Istituto Clinico Humanitas,
Rozzano, Milan, Italy
Site recruitment: Not reported
Andrology Unit Department of Clinical Physiopathology
Florence, Italy
Site recruitment: Not reported
AziendaUSLModena
Modena, Italy
Site recruitment: Not reported
University of Padova Department of Histology, Microbiology and Medical Biotechnologies Clinical Pathology Section & Centre for Male Gamete Cryopreservation
Padova, Italy
Site recruitment: Not reported
Department of Medical Pathophysiology, University of Rome La Sapienza, Lab of Seminology & Immunology of Reproduction
Rome, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Dual Triggering in Patients With a High Immature Oocyte Rate

ClinicalTrials.gov · NCT02813239 · Registry updated: 2016-06-24

Condition / research focus: INFERTILITY
Sponsor: IVI Madrid
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-11. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (other) — also listed as: OVITRELLE (Merck Serono)
hCG + GnRH agonist (other) — also listed as: Ovitrelle (Merck Serono) + Decapeptyl (Ipsen Pharma)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome

ClinicalTrials.gov · NCT02788136 · Registry updated: 2016-06-07

Condition / research focus: Steroidogenesis; Klinefelter Syndrome; Human Chorionic Gonadotropin (hCG) Stimulation
Sponsor: Azienda USL Modena
Countries with listed sites: Italy
Registry dates and results: Start: 2012-02. Completion: 2014-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (drug) — also listed as: hCG

Where the study takes place — 1 listed sites

AziendaUSLModena
Modena, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

ClinicalTrials.gov · NCT01979341 · Registry updated: 2016-05-26

Condition / research focus: Pregnancy; Ovarian Hyperstimulation Syndrome
Sponsor: Antalya IVF
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2013-10. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

final oocyte maturation trigger (procedure) — also listed as: dual trigger: 6500 IU Ovitrelle (hCG) plus 0.2mg triptorelin acetate (GnRH agonist), hCG trigger: 6500 IU Ovitrelle (hCG), agonist trigger: 0.2mg triptorelin acetate (GnRH agonist)

Where the study takes place — 1 listed sites

Antalya IVF
Antalya, Antalya, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility

ClinicalTrials.gov · NCT02739516 · Registry updated: 2016-05-19

Condition / research focus: Unexplained Infertility
Sponsor: Benha University
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (drug)
FSH co-trigger (drug)
Letrozole (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism

ClinicalTrials.gov · NCT02728440 · Registry updated: 2016-04-13

Condition / research focus: Idiopathic Hypogonadotropic Hypogonadism
Sponsor: Gulhane School of Medicine
Countries with listed sites: No country reported
Registry dates and results: Start: 2010-05. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin, human menopausal gonadotropin (drug) — also listed as: Pregnyl ® Organon hCG 1500 IU, Merional ® ARIS 75 IU

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3UnknownINTERVENTIONAL

Use of Cyclosporin A for the Treatment of Recurrent Miscarriage

ClinicalTrials.gov · NCT02706470 · Registry updated: 2016-03-15

Condition / research focus: Miscarriage, Recurrent
Sponsor: Fudan University
Countries with listed sites: China
Registry dates and results: Start: 2016-05. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cyclosporin A (drug)
Dydrogesterone (drug) — also listed as: Duphaston

Where the study takes place — 1 listed sites

Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF

ClinicalTrials.gov · NCT02690870 · Registry updated: 2016-02-25

Condition / research focus: Infertility
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tamoxifen (drug) — also listed as: CAS RN：10540-29-1
Clomiphene (drug) — also listed as: clomiphene citrate

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer

ClinicalTrials.gov · NCT02668965 · Registry updated: 2016-01-29

Condition / research focus: Infertility
Sponsor: Mahidol University
Countries with listed sites: Thailand
Registry dates and results: Start: 2015-12. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intrauterine hCG (pregnyl) (procedure)

Where the study takes place — 1 listed sites

Infertility unit, Siriraj Hospital
Bangkok, Bangkok, Thailand
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders

ClinicalTrials.gov · NCT00415766 · Registry updated: 2016-01-20

Condition / research focus: Infertility
Sponsor: Eugonia
Countries with listed sites: Greece
Registry dates and results: Start: 2013-06. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

rHCG 250ug (drug) — also listed as: Ovitrelle
uHCG 5000 IU (drug) — also listed as: Pregnyl 5000 IU
uHCG 7500 IU (drug) — also listed as: Pregnyl 7500 IU

Where the study takes place — 1 listed sites

Eugonia
Athens, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone

ClinicalTrials.gov · NCT00839319 · Registry updated: 2016-01-11

Condition / research focus: Healthy Males
Sponsor: University of Washington
Countries with listed sites: United States
Registry dates and results: Start: 2009-03. Completion: 2010-11 (may be estimated). Results are posted in this registry.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Acyline (drug) — also listed as: Acyline GhRH antagonist
placebo hCG (no active ingredient) (other) — also listed as: placebo drug
hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
Testosterone gel (drug) — also listed as: Testim

Where the study takes place — 1 listed sites

University of Washington
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients

ClinicalTrials.gov · NCT02293668 · Registry updated: 2016-01-08

Condition / research focus: Infertility
Sponsor: Istanbul University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-11. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FSH 225IU and hMG 225IU (drug)
FSH 150IU and hMG 150IU (drug)
Letrozole 5mg and hMG 150IU (drug)

Where the study takes place — 1 listed sites

Istanbul University School of Medicine
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

ClinicalTrials.gov · NCT02158689 · Registry updated: 2016-01-08

Condition / research focus: Poor Responders
Sponsor: Ercan Bastu
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (drug) — also listed as: Femara
human menopausal gonadotropin (hMG) (drug)

Where the study takes place — 1 listed sites

Department of Obstetrics and Gynecology, Istanbul University School of Medicine
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

ClinicalTrials.gov · NCT01653743 · Registry updated: 2016-01-07

Condition / research focus: Anovulation; Oligo-ovulation; Hypothalamic-pituitary Dysfunction; Polycystic Ovarian Syndrome
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Japan
Registry dates and results: Start: 2012-09. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MSJ-0011 (drug)
urinary hCG (u-hCG) (drug)
Follitropin alpha (drug)

Where the study takes place — 6 listed sites

Hanabusa Women's Central Fertility Clinic
Hyōgo, Japan
Site recruitment: Not reported
Bashamichi Ladies Clinic
Kanagawa, Japan
Site recruitment: Not reported
Sophia Ladies Clinic
Kanagawa, Japan
Site recruitment: Not reported
Ivf Namba Clinic
Osaka, Japan
Site recruitment: Not reported
Ivf Osaka Clinic
Osaka, Japan
Site recruitment: Not reported
Department of Obstetrics and Gynecology, Saitama Medical University Hospital
Saitama, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

ClinicalTrials.gov · NCT02640976 · Registry updated: 2015-12-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human menopausal gonadotrophin (HMG) (drug) — also listed as: Merional®
GnRH antagonist Cetrorelix (drug) — also listed as: Cetrotide®
Human chorionic gonadotrophin (hCG) (drug) — also listed as: Choriomon®

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

IVF Clinical Trial of Two Different Treatment Protocols.

ClinicalTrials.gov · NCT00799929 · Registry updated: 2015-12-24

Condition / research focus: Infertility
Sponsor: New Hope Fertility Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-12. Completion: 2014-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

in vitro fertilization (IVF/ICSI) (other)

Where the study takes place — 1 listed sites

New Hope Fertility Center
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

ClinicalTrials.gov · NCT01863680 · Registry updated: 2015-12-21

Condition / research focus: Luteal Hormone Supplementation in In-vitro Fertilization; Embryo Transfer
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Japan
Registry dates and results: Start: 2013-07. Completion: 2014-10 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

COL-1620 (drug)
Gonadotropin-releasing hormone (GnRH) analogue (drug)
Follicle-stimulating hormone (FSH) (drug)
Human Chorionic Gonadotropin (hCG) (drug)

Where the study takes place — 5 listed sites

Research site
Fujimino, Japan
Site recruitment: Not reported
Research site
Kobe, Japan
Site recruitment: Not reported
Research site
Osaka, Japan
Site recruitment: Not reported
Research site
Sagamihara, Japan
Site recruitment: Not reported
Research site
Yokohama, Kanagawa, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:37 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3UnknownINTERVENTIONAL

Stimulated Intrauterine Insemination Cycles and Unstimulated Intrauterine Insemination Cycles in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT02461173 · Registry updated: 2016-07-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Ovulation detection (procedure)
Choriomon (drug)
shepherd catheter (device)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Letrozole in Assisted Reproductive Technology

ClinicalTrials.gov · NCT02429999 · Registry updated: 2016-07-15

Condition / research focus: to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-04. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrezole plus FSH (drug)
Standard protocol for induction of ovulation (drug)

Where the study takes place — 1 listed sites

of Medicine
Asyut, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

ClinicalTrials.gov · NCT02827656 · Registry updated: 2016-07-12

Condition / research focus: Infertility
Sponsor: Meir Medical Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-08. Completion: 2017-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Decapeptyl (drug)
hCG luteal support (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

ClinicalTrials.gov · NCT02349945 · Registry updated: 2016-07-12

Condition / research focus: Male Infertility
Sponsor: Azienda USL Modena
Countries with listed sites: Germany · Italy
Registry dates and results: Start: 2011-01. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

follitropin alpha (drug) — also listed as: Gonal f

Where the study takes place — 6 listed sites

Zentrums für Reproduktions-medizin und Andrologie Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg
Halle, Germany
Site recruitment: Not reported
Dipartimento di Ginecologia e Medicina della Riproduzione IRCCS Istituto Clinico Humanitas,
Rozzano, Milan, Italy
Site recruitment: Not reported
Andrology Unit Department of Clinical Physiopathology
Florence, Italy
Site recruitment: Not reported
AziendaUSLModena
Modena, Italy
Site recruitment: Not reported
University of Padova Department of Histology, Microbiology and Medical Biotechnologies Clinical Pathology Section & Centre for Male Gamete Cryopreservation
Padova, Italy
Site recruitment: Not reported
Department of Medical Pathophysiology, University of Rome La Sapienza, Lab of Seminology & Immunology of Reproduction
Rome, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Dual Triggering in Patients With a High Immature Oocyte Rate

ClinicalTrials.gov · NCT02813239 · Registry updated: 2016-06-24

Condition / research focus: INFERTILITY
Sponsor: IVI Madrid
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-11. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (other) — also listed as: OVITRELLE (Merck Serono)
hCG + GnRH agonist (other) — also listed as: Ovitrelle (Merck Serono) + Decapeptyl (Ipsen Pharma)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome

ClinicalTrials.gov · NCT02788136 · Registry updated: 2016-06-07

Condition / research focus: Steroidogenesis; Klinefelter Syndrome; Human Chorionic Gonadotropin (hCG) Stimulation
Sponsor: Azienda USL Modena
Countries with listed sites: Italy
Registry dates and results: Start: 2012-02. Completion: 2014-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin (drug) — also listed as: hCG

Where the study takes place — 1 listed sites

AziendaUSLModena
Modena, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

ClinicalTrials.gov · NCT01979341 · Registry updated: 2016-05-26

Condition / research focus: Pregnancy; Ovarian Hyperstimulation Syndrome
Sponsor: Antalya IVF
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2013-10. Completion: 2016-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

final oocyte maturation trigger (procedure) — also listed as: dual trigger: 6500 IU Ovitrelle (hCG) plus 0.2mg triptorelin acetate (GnRH agonist), hCG trigger: 6500 IU Ovitrelle (hCG), agonist trigger: 0.2mg triptorelin acetate (GnRH agonist)

Where the study takes place — 1 listed sites

Antalya IVF
Antalya, Antalya, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility

ClinicalTrials.gov · NCT02739516 · Registry updated: 2016-05-19

Condition / research focus: Unexplained Infertility
Sponsor: Benha University
Countries with listed sites: No country reported
Registry dates and results: Start: 2014-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotropin (drug)
FSH co-trigger (drug)
Letrozole (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism

ClinicalTrials.gov · NCT02728440 · Registry updated: 2016-04-13

Condition / research focus: Idiopathic Hypogonadotropic Hypogonadism
Sponsor: Gulhane School of Medicine
Countries with listed sites: No country reported
Registry dates and results: Start: 2010-05. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human chorionic gonadotropin, human menopausal gonadotropin (drug) — also listed as: Pregnyl ® Organon hCG 1500 IU, Merional ® ARIS 75 IU

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3UnknownINTERVENTIONAL

Use of Cyclosporin A for the Treatment of Recurrent Miscarriage

ClinicalTrials.gov · NCT02706470 · Registry updated: 2016-03-15

Condition / research focus: Miscarriage, Recurrent
Sponsor: Fudan University
Countries with listed sites: China
Registry dates and results: Start: 2016-05. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cyclosporin A (drug)
Dydrogesterone (drug) — also listed as: Duphaston

Where the study takes place — 1 listed sites

Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF

ClinicalTrials.gov · NCT02690870 · Registry updated: 2016-02-25

Condition / research focus: Infertility
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2019-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tamoxifen (drug) — also listed as: CAS RN：10540-29-1
Clomiphene (drug) — also listed as: clomiphene citrate

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Effects of Intrauterine Infusion of hCG at the Time of Embryo Transfer

ClinicalTrials.gov · NCT02668965 · Registry updated: 2016-01-29

Condition / research focus: Infertility
Sponsor: Mahidol University
Countries with listed sites: Thailand
Registry dates and results: Start: 2015-12. Completion: 2016-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intrauterine hCG (pregnyl) (procedure)

Where the study takes place — 1 listed sites

Infertility unit, Siriraj Hospital
Bangkok, Bangkok, Thailand
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders

ClinicalTrials.gov · NCT00415766 · Registry updated: 2016-01-20

Condition / research focus: Infertility
Sponsor: Eugonia
Countries with listed sites: Greece
Registry dates and results: Start: 2013-06. Completion: 2016-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

rHCG 250ug (drug) — also listed as: Ovitrelle
uHCG 5000 IU (drug) — also listed as: Pregnyl 5000 IU
uHCG 7500 IU (drug) — also listed as: Pregnyl 7500 IU

Where the study takes place — 1 listed sites

Eugonia
Athens, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone

ClinicalTrials.gov · NCT00839319 · Registry updated: 2016-01-11

Condition / research focus: Healthy Males
Sponsor: University of Washington
Countries with listed sites: United States
Registry dates and results: Start: 2009-03. Completion: 2010-11 (may be estimated). Results are posted in this registry.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Acyline (drug) — also listed as: Acyline GhRH antagonist
placebo hCG (no active ingredient) (other) — also listed as: placebo drug
hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
hCG (human chorionic gonadotropin) (drug) — also listed as: Pregnyl
Testosterone gel (drug) — also listed as: Testim

Where the study takes place — 1 listed sites

University of Washington
Seattle, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility Patients

ClinicalTrials.gov · NCT02293668 · Registry updated: 2016-01-08

Condition / research focus: Infertility
Sponsor: Istanbul University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-11. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FSH 225IU and hMG 225IU (drug)
FSH 150IU and hMG 150IU (drug)
Letrozole 5mg and hMG 150IU (drug)

Where the study takes place — 1 listed sites

Istanbul University School of Medicine
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

ClinicalTrials.gov · NCT02158689 · Registry updated: 2016-01-08

Condition / research focus: Poor Responders
Sponsor: Ercan Bastu
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2014-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (drug) — also listed as: Femara
human menopausal gonadotropin (hMG) (drug)

Where the study takes place — 1 listed sites

Department of Obstetrics and Gynecology, Istanbul University School of Medicine
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

ClinicalTrials.gov · NCT01653743 · Registry updated: 2016-01-07

Condition / research focus: Anovulation; Oligo-ovulation; Hypothalamic-pituitary Dysfunction; Polycystic Ovarian Syndrome
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Japan
Registry dates and results: Start: 2012-09. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MSJ-0011 (drug)
urinary hCG (u-hCG) (drug)
Follitropin alpha (drug)

Where the study takes place — 6 listed sites

Hanabusa Women's Central Fertility Clinic
Hyōgo, Japan
Site recruitment: Not reported
Bashamichi Ladies Clinic
Kanagawa, Japan
Site recruitment: Not reported
Sophia Ladies Clinic
Kanagawa, Japan
Site recruitment: Not reported
Ivf Namba Clinic
Osaka, Japan
Site recruitment: Not reported
Ivf Osaka Clinic
Osaka, Japan
Site recruitment: Not reported
Department of Obstetrics and Gynecology, Saitama Medical University Hospital
Saitama, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program

ClinicalTrials.gov · NCT02640976 · Registry updated: 2015-12-29

Condition / research focus: Infertility
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-06. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human menopausal gonadotrophin (HMG) (drug) — also listed as: Merional®
GnRH antagonist Cetrorelix (drug) — also listed as: Cetrotide®
Human chorionic gonadotrophin (hCG) (drug) — also listed as: Choriomon®

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

IVF Clinical Trial of Two Different Treatment Protocols.

ClinicalTrials.gov · NCT00799929 · Registry updated: 2015-12-24

Condition / research focus: Infertility
Sponsor: New Hope Fertility Center
Countries with listed sites: United States
Registry dates and results: Start: 2008-12. Completion: 2014-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

in vitro fertilization (IVF/ICSI) (other)

Where the study takes place — 1 listed sites

New Hope Fertility Center
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

ClinicalTrials.gov · NCT01863680 · Registry updated: 2015-12-21

Condition / research focus: Luteal Hormone Supplementation in In-vitro Fertilization; Embryo Transfer
Sponsor: Merck KGaA, Darmstadt, Germany
Countries with listed sites: Japan
Registry dates and results: Start: 2013-07. Completion: 2014-10 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

COL-1620 (drug)
Gonadotropin-releasing hormone (GnRH) analogue (drug)
Follicle-stimulating hormone (FSH) (drug)
Human Chorionic Gonadotropin (hCG) (drug)

Where the study takes place — 5 listed sites

Research site
Fujimino, Japan
Site recruitment: Not reported
Research site
Kobe, Japan
Site recruitment: Not reported
Research site
Osaka, Japan
Site recruitment: Not reported
Research site
Sagamihara, Japan
Site recruitment: Not reported
Research site
Yokohama, Kanagawa, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →